CAR Adjuvant therapy (Vascular Biosciences)

N/A

Report date: 2024/09/14 10:15:50
NME

Base Information

Drug NameCAR Adjuvant therapy (Vascular Biosciences)
Drug Alias NameCAR Adjuvant SL and IV (Vascular Biosciences)CARSKNKDC peptide Adjuvant SL and IV (Vascular Biosciences)
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Hypertension, PulmonarySepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVascular BioSciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVascular BioSciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Hypertension, PulmonarySepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A